PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-11-11

Date Title Company
11-Nov-2020 HRA PHARMA APPOINTS OTC MEDICAL AS DISTRIBUTOR IN THE NETHERLANDS IN A BID TO EXPAND FURTHER IN THE DUTCH MARKET HRA PHARMA
11-Nov-2020 SOTIO Presents Interim Data from its Phase 1/1b Study of SO-C101 in Patients with Advanced Solid Tumors at SITC 2020 B3C newswire
11-Nov-2020 SOTIO Presents Interim Data from its Phase 1/1b Study of SO-C101 in Patients with Advanced Solid Tumors at SITC 2020 B3C newswire
11-Nov-2020 Ending the 'diversity gap' in research: Shadow Science Minister joins pharma experts and BAME leaders to take action Clinical Trial Diversity
11-Nov-2020 MSF: Governments must demand pharma make all COVID-19 vaccine licensing deals public MSF
11-Nov-2020 Almac Group Welcomes COVID-19 Vaccine Trial News Announced by Pfizer & BioNTech Almac Group
11-Nov-2020 OncoHost to Present Data on Predicting Host Response to Immunotherapy in Melanoma Patients at SITC 2020 OncoHost
11-Nov-2020 Healthcare at Home launches Sciensus Rare to connect emerging biotech and large pharma companies with rare disease patients in Europe and beyond Healthcare at Home
11-Nov-2020 NICE gives green light for chemotherapy-free combination, Venclyxto® (venetoclax) plus obinutuzumab for all front-line patients with chronic lymphocytic leukaemia – the UK’s most common chronic blood cancer AbbVie
11-Nov-2020 GAMA Healthcare to Open New Infection Prevention Solution Super Hub GAMA Healthcare
11-Nov-2020 The first interim data analysis of the Sputnik V vaccine against COVID-19 phase III clinical trials in the Russian Federation demonstrated 92% efficacy Gamaleya Center
11-Nov-2020 Medicago announces positive Phase 1 results for its COVID-19 vaccine candidate Medicago
11-Nov-2020 Data showing SARS-CoV-2 reactive T cells are associated with protection from COVID-19 – and can be both detected and measured using Oxford Immunotec’s T-SPOT®technology - is published by Public Health England and Oxford Immunotec Oxford Immunotec Global PLC
11-Nov-2020 Angiocrine Bioscience Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to AB-205 (Universal E-CEL® Cell Therapy) to Treat Organ Vascular Niche Injuries for the Prevention of Severe Toxicities in Lymphoma Patients undergoing Curative High-Dose Therapy with Autologous Stem Cell Transplantation Angiocrine Bioscience, Inc.
11-Nov-2020 Co-Diagnostics, Inc. CoPrimers(TM) Shown to be Effective in COVID-19 Saliva PCR Tests Without Sample Extraction Co-Diagnostics
11-Nov-2020 Anticoccidial Drugs Market Size To Hike At 3.61% CAGR Between 2020 to 2025 Market Data Forecast
11-Nov-2020 Autologous Biologics Market to Scale new heights in the next decade – Persistence Market Research MARKITWIRED
11-Nov-2020 Future Market Insights Analyzes Impact of COVID-19 on Parasomnia Treatment Market; Stakeholders to Focus on Long-term Dimensions MARKITWIRED
11-Nov-2020 PET Injectors Market to Suffer Slight Decline in 2020, Efforts to Mitigate Coronavirus-related Disruptions Ramp Up MARKITWIRED
11-Nov-2020 PET Injectors Market to Suffer Slight Decline in 2020, Efforts to Mitigate Coronavirus-related Disruptions Ramp Up MARKITWIRED